LONDON, August 20, 2018 /PRNewswire/ --
Syringe, Insulin, Volumetric, Ambulatory, Patient Controlled Analgesia, Implantable, Enteral, Gastroenterology, Diabetes, Analgesia & Pain Management, Chemotherapy, Paediatrics & Neonatology, Hospital, Home Healthcare, Ambulatory Surgical Centres
The global infusion devices market was valued at $2.1bn in 2017 and is estimated to reach $3.9bn by 2028, growing at a CAGR of 5.6% from 2018-2028. In 2017, the volumetric infusion pumps submarket was the largest contributor to the global infusion devices market by product type.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 176-page report you will receive 88 tables and 46 figures- all unavailable elsewhere.
The 176-page report provides clear detailed insight into the global infusion devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
• Global Infusion Devices market forecasts from 2018-2028
• This report also breaks down the revenue forecast for global infusion devices market by product type:
• Syringe Infusion Pumps
• Insulin Infusion Pumps
• Volumetric Infusion Pumps
• Ambulatory Infusion Pumps
• Patient Controlled Analgesia Pumps
• Implantable Infusion Pumps
• Enteral Infusion Pumps
• This report also breaks down the revenue forecast for global infusion devices market by application:
• Analgesia & Pain Management
• Paediatrics & Neonatology
• Other Applications
• This report also breaks down the revenue forecast for global infusion devices market by end-user:
• Home Healthcare
• Ambulatory Surgical Centres
• Other End-User
• This report also breaks down the revenue forecast for global infusion devices market by regional and national market:
• North America: US, Mexico, Canada
• Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, Australia, India, South Korea, Rest of Asia-Pacific
• LAMEA: Brazil, Turkey, Saudi Arabia, Republic of South Africa, Rest of LAMEA
Each regional market is further segmented by product type, application, end-user and country
• This report discusses 10 leading companies involved in the infusion devices market. It contains overviews of the companies' activities, strategies and recent financial results:
• Baxter International Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• CME Medical UK Ltd.
• Fresenius SE & Co. KGaA
• ICU Medical, Inc.
• Johnson & Johnson
• Moog Inc.
• Smiths Group plc
• Terumo Medical Corporation
• This report provides Porter's Five Forces Analysis of the global infusion devices market. This report also discusses factors that drive and restrain the market as well as opportunities in the market. Moreover, this report provides an analysis on patent and top winning strategies.
Visiongain's study is for everybody needing commercial analyses for the Infusion Devices market and leading companies. You will find data, trends and predictions. Please order our report now.
Buy our report today Global Infusion Devices Market Forecast 2018-2028: Syringe, Insulin, Volumetric, Ambulatory, Patient Controlled Analgesia, Implantable, Enteral, Gastroenterology, Diabetes, Analgesia & Pain Management, Chemotherapy, Paediatrics & Neonatology, Hospital, Home Healthcare, Ambulatory Surgical Centres
To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website : https://www.visiongain.com/report/global-infusion-devices-market-forecast-2018-2028/
B. Braun Melsungen AG
Becton & Dickson & Co
Boston Scientific Corporation
Caesarea Medical Electronics (CME)
Codman and Shurtleff
D. Medical Industries
Disetronic Medical Systems
Generex Biotechnology Corporation
Hanraj Nayyar Medical India
Johnson and Johnson
Kimberly Clark Corporation
Micrel Medical Devices
Q Core Medical
Smiths Group plc
Symbios Medical Products
Tandem Diabetics Care
Terumo Medical Corporation
To see a report overview please e-mail Sara Peerun on [email protected]